Black Rock climbs on high-grade graphite hits


Published 08-OCT-2015 16:27 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Shares in Black Rock Mining (ASX:BKT) have climbed on high-grade graphite drilling results – and confirmation it plans to have a JORC resource in the bag by the end of the year.

The ASX-listed graphite player told the market today that it had received assays from the first nine holes targeting the Ulanzi prospect out of an overall program of 17 including:

  • 92m @ 8.5% total graphitic carbon (TGC) including 12m @ 14% TGC
  • 52m @ 10.4% TGC including 8m @ 13.81% TGC
  • 32m @ 9.25% TGC including 10m @ 16.32% TGC

The assay results mean 1000m of the strike drill tested so far is consistently grading at about 10% TGC.

It could get even better for BKT, with assays from the remaining eight RC holes from the 17 hole program due back by the middle of this month.

The results from the initial nine holes were enough for BKT to confirm that it would drill another 30 holes into the Ulanzi prospect by the end of the year, with drilling due to start late this month.

The holes will be drilled as infill holes to firm up the Ulanzi prospect to the north and south even further, but recent step-out trenching and pitting to the north and south has extended the strike length at Ulanzi by almost 50%.

BKT told its investors that the program had extended the strike length out to 5.5km, from its previous length of 3km.

It also said that the 30 hole program would have the effect of generating a resource by the end of the year.

BKT shareholders voted with their buy orders today, with its price soaring up 7.4% nearing the end of trading to 8.7c on the back of the news.

However, BKT shares did hit a high of 9.2 shares earlier in the day, with nearly 2 million shares changing hands today – well above its 30-day trading average of just under 480,000 shares.

BKT managing director Steven Tambaris told shareholders that Ulanzi was proving to be a wonder deposit.

“In a short but intensive three month period, Ulanzi has been transformed from a few lines of test samples into the drill-out of a [more than] 5km long graphite mineralised structure with significant resource potential,” he said.

“Every drill hole at Ulanzi is expected to add resource tonnes.”

Black Rock Mining (ASX:BKT) and Ulanzi

The Ulanzi prospect is part of the broader Mahenge tenure in Tanzania.

BKT secured more than 1,500km2 of tenements earlier this year, quickly trenching and infill drilling to fast-track its commercial potential.

Tanzania sits on top of the largest source of graphite mineralisation in the world, close to the famous Cabo Delgado region of Mozambique. There’s more graphite in this part of East Africa than the rest of the world combined.

Graphite is becoming a hot commodity and could potentially become one of the world’s most ubiquitous minerals once new lithium-ion batteries start to become mass-produced products.

Not too long ago BKT was trading under the name of Green Rock Energy, exploring geothermal energy resources in South Australia.

Since March 2015 however, BKT has changed tact to pursue a much more commercially viable resource: Graphite.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free